Managing director, the Foundry Group
Founder and CEO of Brooks Bell Inc.
Chair, Department of Chemical Physiology, The Scripps Research Institute; Co-director, Center for Physiological Proteomics, The Scripps Research Institute
Co-Founder and CEO, Wetpaint
The San Diego Biotechnology Network is coordinating a symposium that highlights drug development outside the San Diego region. Rondaxe, Helsinn Advanced Synthesis, and TD2 are making presentations on clinical development, API manufacturing, and CMC services/consulting and clinical development. More information and online registration is available here.